Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1981 1
1982 3
1983 2
1984 6
1985 4
1986 3
1987 1
1988 2
1989 6
1990 8
1991 7
1992 11
1993 8
1994 9
1995 8
1996 7
1997 5
1998 8
1999 16
2000 10
2001 16
2002 20
2003 28
2004 31
2005 33
2006 37
2007 29
2008 44
2009 68
2010 85
2011 72
2012 111
2013 115
2014 143
2015 147
2016 173
2017 158
2018 193
2019 201
2020 277
2021 321
2022 375
2023 339
2024 440
2025 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,233 results

Results by year

Filters applied: . Clear all
Page 1
Autophagy and multidrug resistance in cancer.
Li YJ, Lei YH, Yao N, Wang CR, Hu N, Ye WC, Zhang DM, Chen ZS. Li YJ, et al. Among authors: hu n. Chin J Cancer. 2017 Jun 24;36(1):52. doi: 10.1186/s40880-017-0219-2. Chin J Cancer. 2017. PMID: 28646911 Free PMC article. Review.
Prevalence and control of diabetes in Chinese adults.
Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G; 2010 China Noncommunicable Disease Surveillance Group. Xu Y, et al. Among authors: hu n. JAMA. 2013 Sep 4;310(9):948-59. doi: 10.1001/jama.2013.168118. JAMA. 2013. PMID: 24002281
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase.
Guo Y, Liu Y, Hu N, Yu D, Zhou C, Shi G, Zhang B, Wei M, Liu J, Luo L, Tang Z, Song H, Guo Y, Liu X, Su D, Zhang S, Song X, Zhou X, Hong Y, Chen S, Cheng Z, Young S, Wei Q, Wang H, Wang Q, Lv L, Wang F, Xu H, Sun H, Xing H, Li N, Zhang W, Wang Z, Liu G, Sun Z, Zhou D, Li W, Liu L, Wang L, Wang Z. Guo Y, et al. Among authors: hu n. J Med Chem. 2019 Sep 12;62(17):7923-7940. doi: 10.1021/acs.jmedchem.9b00687. Epub 2019 Aug 19. J Med Chem. 2019. PMID: 31381333
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.
Kato K, Doki Y, Chau I, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Makino T, Blum Murphy M, Amaya-Chanaga C, Patel A, Hu N, Matsumura Y, Kitagawa Y, Ajani J. Kato K, et al. Among authors: hu n. Cancer Med. 2024 May;13(9):e7235. doi: 10.1002/cam4.7235. Cancer Med. 2024. PMID: 38716626 Free PMC article. Clinical Trial.
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.
Benschop RJ, Chow CK, Tian Y, Nelson J, Barmettler B, Atwell S, Clawson D, Chai Q, Jones B, Fitchett J, Torgerson S, Ji Y, Bina H, Hu N, Ghanem M, Manetta J, Wroblewski VJ, Lu J, Allan BW. Benschop RJ, et al. Among authors: hu n. MAbs. 2019 Aug/Sep;11(6):1175-1190. doi: 10.1080/19420862.2019.1624463. Epub 2019 Jun 10. MAbs. 2019. PMID: 31181988 Free PMC article.
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial.
Reck M, Ciuleanu TE, Schenker M, Bordenave S, Cobo M, Juan-Vidal O, Reinmuth N, Richardet E, Felip E, Menezes J, Cheng Y, Mizutani H, Zurawski B, Alexandru A, Carbone DP, Lu S, John T, Aoyama T, Grootendorst DJ, Hu N, Eccles LJ, Paz-Ares LG. Reck M, et al. Among authors: hu n. Eur J Cancer. 2024 Nov;211:114296. doi: 10.1016/j.ejca.2024.114296. Epub 2024 Aug 25. Eur J Cancer. 2024. PMID: 39270380 Free article. Clinical Trial.
Dysregulated Coagulation in Parkinson's Disease.
Wang X, Li W, Zhao X, Hu N, Wang X, Xiao X, Yang K, Sun T. Wang X, et al. Among authors: hu n. Cells. 2024 Nov 13;13(22):1874. doi: 10.3390/cells13221874. Cells. 2024. PMID: 39594622 Free PMC article. Review.
Dementia and metabolic syndrome: a bibliometric analysis.
Peng T, Yang Y, Ma J, Xu P, Xie X, Hu N, Yan Y. Peng T, et al. Among authors: hu n. Front Aging Neurosci. 2024 Jun 12;16:1400589. doi: 10.3389/fnagi.2024.1400589. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38934020 Free PMC article.
3,233 results